Wai Nam Liu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Monoclonal Antibody

Natural Killer Cells

Top Venues

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Isha Karnik, Zhisheng Her, Shu Hui Neo, Wai Nam Liu, Qingfeng Chen
Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment. Pharmaceutics 15 (6) (2023)
Isha Karnik, Zhisheng Her, Shu Hui Neo, Wai Nam Liu, Qingfeng Chen
Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment. Pharmaceutics 15 (6) (2023)
Wai Nam Liu, Wing Yan So, Sarah L Harden, Shin Yie Fong, Melissa Xin Yu Wong, Wilson Wei Sheng Tan, Sue Yee Tan, Jessica Kai Lin Ong, Ravisankar Rajarethinam, Min Liu, Jia Ying Cheng, Lisda Suteja, Joe Poh Sheng Yeong, N Gopalakrishna Iyer, Darren Wan-Teck Lim, Qingfeng Chen
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model. Science advances 8 (47) (2022)
Wing Yan So, Wai Nam Liu, Adrian Kee Keong Teo, Guy A Rutter, Weiping Han
Paired box 6 programs essential exocytotic genes in the regulation of glucose-stimulated insulin secretion and glucose homeostasis. Science translational medicine 13 (600) (2021)
Wai Nam Liu, Shin Yie Fong, Wilson Wei Sheng Tan, Sue Yee Tan, Min Liu, Jia Ying Cheng, Sherlly Lim, Lisda Suteja, Edwin Kunxiang Huang, Jerry Kok Yen Chan, Narayanan Gopalakrishna Iyer, Joe Poh Sheng Yeong, Darren Wan-Teck Lim, Qingfeng Chen
Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy. Cancers 12 (4) (2020)